Glaukos Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$19Mgeneral payments (2019-2025)
$1.2Mresearch payments (2019-2025)
18,399clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $1.5M
2020 $1.3M
2021 $1.9M
2022 $2.0M
2023 $3.7M
2024 $3.5M
2025 $5.1M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Ophthalmology $13M
Optometrist $2.8M
Emergency Medicine $1.3M
Glaucoma Specialist $964K
Cornea and External Diseases Specialist $295K
Retina Specialist $234K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Gilbert Kliman Menlo Park, CA Ophthalmology $1,521,728.76
Leana Wen Baltimore, MD Emergency Medicine $1,292,767.31
Mark Gallardo Las Cruces, NM Ophthalmology $999,285.89
Oluwatosin Smith Dallas, TX Ophthalmology $829,684.94
Stuart Stoll Beverly Hills, CA Ophthalmology $669,334.73
Daniel Terveen Sioux Falls, SD Ophthalmology $514,235.46
Stephanie Woo Lake Havasu City, AZ Optometrist $413,190.26
Jonathan Myers Philadelphia, PA Ophthalmology $290,924.64
Kuldev Singh Stanford, CA Ophthalmology $281,419.85
Savak Teymoorian Laguna Hills, CA Ophthalmology $269,842.27

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.